March 14, 2018 / 7:24 AM / 9 months ago

Drugmaker Hikma posts lower-than-expected 2017 profit

March 14 (Reuters) - Hikma Pharmaceuticals Plc reported lower-than-expected full-year core earnings on Wednesday, hurt by weakness in its generic drugs business.

The Jordan-based drugmaker said earnings before interest, tax, depreciation and amortisation (EBITDA) fell 5 percent to $468 million for the year ended Dec. 31, missing analysts’ estimate of $469.9 million, according to Thomson Reuters I/B/E/S.

Revenue fell marginally to $1.94 billion, in line with estimates. (Reporting By Justin George Varghese in Bengaluru Editing by Saumyadeb Chakrabarty)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below